Metoclopramide and Risk of Pheochromocytoma Crisis: A Causality Assessment Using Literature and VigiBase Data
Merhawi Bahta, Abraham Dawit, Million Okubazghi, Mulugeta Russom · 2026
Read Metoclopramide and Risk of Pheochromocytoma Crisis: A Causality Assessment Using Literature and VigiBase Data by Merhawi Bahta, Abraham Dawit, Million Okubazghi, Mulugeta Russom (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13222551.txt.
Description
Merhawi Bahta and co-authors assess whether the anti-nausea drug metoclopramide can trigger pheochromocytoma crisis, in a 2026 pharmacovigilance study. The link rested mostly on case reports about this adrenal tumor emergency. Data came from published literature plus the World Health Organization's global safety database, VigiBase, searched in February 2025.
Sixty-two unique cases were found, nearly all serious, with twelve deaths. In many, the crisis first revealed an undiagnosed tumor. Formal scoring rated most published cases as probable or possible drug reactions, and population-level criteria all pointed the same way. The authors support keeping the drug contraindicated when this tumor is known or suspected.
Catalog record
| CREATOR | Merhawi Bahta, Abraham Dawit, Million Okubazghi, Mulugeta Russom |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |